Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
March 26, 2022
Prevalence, severity, outcomes, and risk factors of COVID-19 in multiple sclerosis: An observational study in the Middle East
Raed Alroughani, Jihad Inshasi, Jasem Al-Hashel, et al.
Multiple Sclerosis and Related Disorders
|
May 19, 2026
Long-term Real-world Safety and Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE Experience
Bassem Yamout, Ahmad Shatila, Jihad Inshasi, et al.
SAGE Open Medicine
|
April 3, 2019
Rescue treatment in patients with poorly responsive Guillain-Barre syndrome
Ayman Mahmoud Alboudi, Pournamy Sarathchandran, Samar Sameer Geblawi, et al.
Neurology and Therapy
|
June 22, 2020
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
Raed Alroughani, Jihad Inshasi, Abdullah Al-Asmi, et al.
Stroke Research and Treatment
|
April 15, 2017
Revisiting Hemicraniectomy: Late Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Stroke and the Role of Infarct Growth Rate
Saadat Kamran, Naveed Akhtar, Abdul Salam, et al.
Translational Stroke Research
|
March 7, 2018
Factors that Can Help Select the Timing for Decompressive Hemicraniectomy for Malignant MCA Stroke
Saadat Kamran, Abdul Salam, Naveed Akhtar, et al.
Neurology and Therapy
|
June 22, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
Neurology and Therapy
|
June 17, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
The International Journal of Neuroscience
|
February 19, 2011
Will new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle East
Dirk Deleu, Issa Alsharoqi, Mohammed Ali Al Jumah, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
July 12, 2017
Predictors of In-Hospital Mortality after Decompressive Hemicraniectomy for Malignant Ischemic Stroke
Saadat Kamran, Abdul Salam, Naveed Akhtar, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
March 26, 2022
Prevalence, severity, outcomes, and risk factors of COVID-19 in multiple sclerosis: An observational study in the Middle East
Raed Alroughani, Jihad Inshasi, Jasem Al-Hashel, et al.
Multiple Sclerosis and Related Disorders
|
May 19, 2026
Long-term Real-world Safety and Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE Experience
Bassem Yamout, Ahmad Shatila, Jihad Inshasi, et al.
SAGE Open Medicine
|
April 3, 2019
Rescue treatment in patients with poorly responsive Guillain-Barre syndrome
Ayman Mahmoud Alboudi, Pournamy Sarathchandran, Samar Sameer Geblawi, et al.
Neurology and Therapy
|
June 22, 2020
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
Raed Alroughani, Jihad Inshasi, Abdullah Al-Asmi, et al.
Stroke Research and Treatment
|
April 15, 2017
Revisiting Hemicraniectomy: Late Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Stroke and the Role of Infarct Growth Rate
Saadat Kamran, Naveed Akhtar, Abdul Salam, et al.
Translational Stroke Research
|
March 7, 2018
Factors that Can Help Select the Timing for Decompressive Hemicraniectomy for Malignant MCA Stroke
Saadat Kamran, Abdul Salam, Naveed Akhtar, et al.
Neurology and Therapy
|
June 22, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
Neurology and Therapy
|
June 17, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
The International Journal of Neuroscience
|
February 19, 2011
Will new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle East
Dirk Deleu, Issa Alsharoqi, Mohammed Ali Al Jumah, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
July 12, 2017
Predictors of In-Hospital Mortality after Decompressive Hemicraniectomy for Malignant Ischemic Stroke
Saadat Kamran, Abdul Salam, Naveed Akhtar, et al.
Page
of 5